33 studies found for:    Open Studies | "Refractive Errors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Refractive Errors"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Condition: Refractive Error
Intervention:
2 Unknown  Piggyback Sulcoflex Toric IOL for Correcting Refractive Error Following Corneal Transplantation
Conditions: Refractive Error;   Corneal Implantation;   Intraocular Lens Implantation
Interventions: Procedure: toric intraocular lens implantation;   Procedure: Sulcoflex intraocular lens implantation
3 Recruiting Optical Defocus to Stimulate Eye Elongation in Hyperopia
Conditions: Hyperopia;   Refractive Error
Interventions: Device: Simultaneous Vision Bifocal Soft Contact Lenses;   Device: Single Vision Soft Contact Lenses
4 Recruiting Dispensing Study to Assess Visual Performance of Prototype Contact Lenses
Conditions: Presbyopia;   Refractive Error
Intervention: Device: Etafilcon A, Lotrafilcon B , Senofilcon A
5 Recruiting Bifocal Lenses In Nearsighted Kids
Condition: Refractive Errors
Interventions: Device: Biofinity Multifocal D +1.50 add;   Device: Biofinity Multifocal D +2.50 add;   Device: Biofinity
6 Recruiting FID# 114657 in Contact Lens Wearers
Conditions: Refractive Error;   Symptoms of Ocular Dryness
Interventions: Drug: FID# 114657 eye drops (10 ml);   Drug: Saline eye drops (15 ml);   Device: Habitual contact lenses
7 Unknown  Safety and Efficacy Study to Evaluate the Treatment of Both Near and Distance Vision in a Simultaneous Laser Procedure
Conditions: Myopia;   Hyperopia;   Presbyopia;   Refractive Error
Intervention: Procedure: Supracor
8 Not yet recruiting Clinical Evaluation of MyDay™ and 1-DAY ACUVUE® TruEye®
Condition: Refractive Error
Interventions: Device: Stenfilcon A contact lenses;   Device: Narafilcon A contact lenses
9 Recruiting Comparison of Intraocular Lens Power Calculation Methods After Corneal Laser Refractive Surgery in Axial and Refractive Ammertropia
Conditions: Cataract;   Refractive Errors
Intervention:
10 Recruiting A New More Efficient Cycloplegia Scheme
Condition: Refractive Errors
Interventions: Drug: Cyclopentolate;   Drug: Cyclopentolate+tropicamide+phenylephrine
11 Unknown  The Effect of Gabapentin (Neurentin) and Pregabalin (Lyrica) in Pain Reduction After Photorefractive Keratectomy
Condition: Refractive Errors
Intervention: Drug: Pregabalin
12 Recruiting The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children
Condition: Myopia
Intervention: Device: massager
13 Not yet recruiting Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation
Condition: Myopia
Interventions: Other: Spectacles with red-blocking tint;   Other: Spectacles with holographic diffuser and color neutral tint;   Other: Spectacles with holographic diffuser and red-blocking tint;   Other: Spectacles with color neutral tint
14 Unknown  The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
Condition: Myopia
Intervention:
15 Recruiting Efficacy Study of Different Lens Treatments on Chinese Adolescent Myopia
Condition: Progressive Myopia
Interventions: Other: Spectacles;   Other: Myovision;   Other: Orthokeratology
16 Unknown  Study of Myopia Prevention in Children With Low Concentration of Atropine
Condition: Myopia
Interventions: Drug: atropine;   Drug: tropicamide
17 Recruiting A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Condition: Choroidal Neovascularization Secondary to Pathologic Myopia
Intervention: Drug: Ranibizumab
18 Recruiting Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condition: Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Interventions: Drug: Ranibizumab 0.5mg;   Drug: Rranibizumab 0.5 mg;   Drug: Verteporfin PDT
19 Recruiting Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
Condition: Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
Intervention: Drug: Bevazizumab intravitreal injection
20 Recruiting Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction
Condition: Hyperopia
Interventions: Procedure: Small incision lenticule extraction;   Device: ReLEx®  (SMILE)

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years